PepGen director granted options for 34,000 shares

PepGen Inc. director Laurie Keating reported a new compensation award on a Form 4.

Rhea-AI Filing Summary

PepGen Inc. director Laurie Keating reported a new compensation award on a Form 4. She received a stock option to buy 34,000 shares of PepGen common stock at an exercise price of $1.79 per share, expiring on June 17, 2036.

The option vests in full on the earlier of the first anniversary of the grant date or the date of the next Annual Meeting, as long as she continues serving as a director, unless the board decides otherwise. After this grant, Keating holds options covering 34,000 underlying shares from this award.

Insider Trade Summary

Grant/Award: 34,000 shares

Grant/Award 1 txn

Insider KEATING LAURIE

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	34,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 34,000 contracts (Direct)

Footnotes (1)

1. F1. This option shall vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting; provided, however, that all vesting shall cease if the individual ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting.

Key Figures

Option grant size: 34,000 shares Exercise price: $1.79 per share Expiration date: June 17, 2036 +1 more

4 metrics

Option grant size 34,000 shares Stock Option (Right to Buy) granted to director

Exercise price $1.79 per share Conversion or exercise price of stock option

Expiration date June 17, 2036 Option expiration for director grant

Shares underlying option 34,000 shares Underlying common stock covered by option

Key Terms

Stock Option (Right to Buy), exercise price, Annual Meeting, Board of Directors

4 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

exercise price financial

"conversion_or_exercise_price: 1.7900"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Annual Meeting financial

"earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting"

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

Board of Directors financial

"unless the Board of Directors determines that the circumstances warrant continuation of vesting"

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did PepGen (PEPG) director Laurie Keating report in this Form 4?

Laurie Keating reported receiving a stock option grant for 34,000 PepGen shares. The option is a compensation award, not an open‑market trade, and gives her the right to buy common stock at a fixed exercise price of $1.79 per share.

What are the key terms of Laurie Keating’s PepGen stock option grant?

The grant covers 34,000 shares of PepGen common stock at a $1.79 exercise price, expiring June 17, 2036. It is held directly by Keating and represents a right to buy, not an immediate ownership of, the underlying common shares.

How does the PepGen stock option granted to Laurie Keating vest?

The option vests in full on the earlier of the first anniversary of the grant date or the next Annual Meeting. Vesting continues only while she serves as a director, unless the board determines that circumstances justify continued vesting after service ends.

Is Laurie Keating’s PepGen Form 4 a stock purchase or a compensation award?

The Form 4 reflects a compensation award, not an open‑market purchase. Keating received a grant of stock options with a $1.79 exercise price, classified as a grant or award acquisition, giving her the right to buy shares in the future if she chooses.

Did Laurie Keating sell any PepGen shares in this Form 4 filing?

No sales were reported in this filing. The transaction is a single option grant to acquire rights over 34,000 underlying shares, with no disposal or sale codes shown, and no transactions classified as sales or tax‑related dispositions in the transaction summary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 04:03 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KEATING LAURIE

(Last) (First) (Middle)

C/O PEPGEN INC.

321 HARRISON AVE 8TH FLOOR

(Street)

BOSTON MASSACHUSETTS 02118

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PepGen Inc. [ PEPG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.79	06/18/2026		A		34,000		(1)	06/17/2036	Common Stock	34,000	$0	34,000	D

Explanation of Responses:

1. This option shall vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting; provided, however, that all vesting shall cease if the individual ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting.

	/s/ Noel Donnelly, as attorney-in-fact	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)